Yoko Mullen

Yoko Mullen

Auto-generated profile, based on publicly available information

Yoko Mullen

Beckman Research Institute of the City of Hope, Duarte, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Experimental Hematology
Verified
Journal Article
Closed access
SASadaki Asari
Sadaki Asari
SIShin Itakura
Shin Itakura
KFKevin Ferreri
Kevin Ferreri
CLChih-Pin Liu
Chih-Pin Liu
YKYoshikazu Kuroda
Yoshikazu Kuroda
YMYoko Mullen
Yoko Mullen

27 June 2010 in Transplantation
Verified
Journal Article
Closed access
TITAIHEI ITO
TAIHEI ITO
SIShin Itakura
Shin Itakura
ITIvan Todorov
Ivan Todorov
JRJeffrey Rawson
Jeffrey Rawson
SASadaki Asari
Sadaki Asari
YMYoko Mullen
Yoko Mullen
Background. Bone marrow-derived mesenchymal stem cells (MSCs) are known to produce vascular endothelial growth factor. We hypothesize that co-transplantation of MSCs and islets promotes revascularization and improves islet graft function. Methods. Lewis rat islets were infused into the liver of streptozotocin-diabetic syngeneic recipients or transplanted under the renal capsule of nonobese diabetic severe combined immunodeficiency (NOD SCID) mice with MSCs isolated from Lewis bone marrow and expanded in culture. Results. Co-transplantation of 500 islets and 107 MSCs (islet-MSCs) reversed diabetes in all eight recipients, whereas islet-alone transplantation achieved euglycemia in 3 of 10 recipients. With 300 islets, five of nine islet-MSCs and 1 of 10 islets-alone recipients reversed diabetes. Results of intravenous glucose tolerance tests performed on day 56 were significantly better in islet-MSCs than islet-alone recipients. One week after transplantation, well-preserved islet structure and higher number of capillaries were found in the liver of islet-MSCs recipients, whereas islet-alone grafts were fragmented with very few capillaries. Islets showed a similar morphology when transplanted with MSCs in nonobese diabetic severe combined immunodeficiency mice with a significantly higher capillary per β-cell ratio than that in islet-alone grafts (0.135±0.046 vs. 0.052±0.028 capillary segments per β-cell, P<0.01). One week after transplantation, islets were surrounded by MSCs labeled with carboxyfluorescein succinimidyl ester or Qdot nanocrystals, and some labeled MSCs positively stained for vascular endothelial growth factor or von Willebrand factor. Conclusion. Our results demonstrate the improvement of islet graft morphology and function by co-transplantation with MSCs. This improvement is attributable, at least in part, to the promotion of graft revascularization mediated by MSCs.

11 February 2005 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
TMTakeru Matsuda
Takeru Matsuda
KOKeiko Omori
Keiko Omori
TVTommy Vuong
Tommy Vuong
MPMichael Pascual
Michael Pascual
LVLuis Valiente
Luis Valiente
YMYoko Mullen
Yoko Mullen
Nonspecific inflammation is associated with primary graft nonfunction (PNF). Inflammatory islet damage is mediated at least partially by pro-inflammatory cytokines, such as interleukin-1β (IL-1β) an...

1 April 2017 in Pancreas
Verified
Journal Article
Open access
PDF file
YMYoko Mullen
Yoko Mullen
In 1974, the discovery of a mouse and a rat that spontaneously developed hyperglycemia led to the development of 2 autoimmune diabetes models: nonobese diabetic (NOD) mouse and Bio-Breeding rat. These models have contributed to our understanding of autoimmune diabetes, provided tools to dissect autoimmune islet damage, and facilitated development of early detection, prevention, and treatment of type 1 diabetes. The genetic characterization, monoclonal antibodies, and congenic strains have made NOD mice especially useful. Although the establishment of the inbred NOD mouse strain was documented by Makino et al (Jikken Dobutsu. 1980;29:1–13), this review will focus on the not-as-well-known history leading to the discovery of a glycosuric female mouse by Yoshihiro Tochino. This discovery was spearheaded by years of effort by Japanese scientists from different disciplines and dedicated animal care personnel and by the support of the Shionogi Pharmaceutical Company, Osaka, Japan. The history is based on the early literature, mostly written in Japanese, and personal communications especially with Dr Tochino, who was involved in diabetes animal model development and who contributed to the release of NOD mice to the international scientific community. This article also reviews the scientific contributions made by the Bio-Breeding rat to autoimmune diabetes.

1 May 2013 in Biomaterials
Verified
Journal Article
Closed access
SLSophia W. Liao
Sophia W. Liao
JRJeffrey Rawson
Jeffrey Rawson
KOKeiko Omori
Keiko Omori
KIKohei Ishiyama
Kohei Ishiyama
DMDavoud Mozhdehi
Davoud Mozhdehi
YMYoko Mullen
Yoko Mullen

13 May 2011 in Diabetologia
Verified
Journal Article
Closed access
PDF file
KOKeiko Omori
Keiko Omori
MMM. Mitsuhashi
M. Mitsuhashi
KIK. Ishiyama
K. Ishiyama
INI. Nair
I. Nair
JRJ. Rawson
J. Rawson
YMY. Mullen
Y. Mullen